Target intelligence / Profile preview

BCL2 interacting protein 3 pseudogene 41 (BNIP3P41)

Target
BNIP3P41
Molecular classification
Other (pseudogene)
01

Overview

BNIP3P41 stands for "BCL2 interacting protein 3 pseudogene 41," which is a human gene classified as a pseudogene—a DNA sequence related to the BNIP3 family members but does not produce a functional protein[1][2]. Pseudogenes are remnants of once-functional genes that have lost their protein-coding ability due to mutations. While the functional BNIP3 and BNIP3L (NIX) proteins are mitochondrial stress sensors involved in cell death, hypoxia response, and disease, BNIP3P41 itself does not encode any active protein and is not recognized as a therapeutic target[1][2]. There is no substantive data linking BNIP3P41 to biological function, disease role, or pharmacological intervention. If you require structured information for the functional BNIP3 protein, which is a biologically active mitochondrial BH3-only protein involved in apoptosis and autophagy, please specify; BNIP3P41 itself is not suitable for therapeutic targeting or molecular pharmacology[1][2].

Other names
No documented common aliases; however, it is related to the functional genes BNIP3 (BCL2-interacting protein 3) and BNIP3L (BNIP3-like/NIX)
02

Mechanism of action

None applicable for BNIP3P41 (see above)

03

Biological functions

None (pseudogenes generally do not encode functional proteins; functions attributed to the BNIP3 family—such as apoptosis, autophagy, cell death—are not applicable to BNIP3P41 itself)
04

Disease associations

None for BNIP3P41 directly; however, BNIP3 and BNIP3L are involved in cancer, cardiovascular disease, and regulation of cell death. No evidence links BNIP3P41 specifically to disease.
05

Safety considerations

None specific to BNIP3P41; as a pseudogene, it has no therapeutic relevance or direct safety considerations
06

Interacting drugs

None (no drugs are known to interact with BNIP3P41; drugs targeting BNIP3 or related pathways would not affect BNIP3P41)
07

Biomarkers

None for BNIP3P41; no evidence that BNIP3P41 is used as a biomarker

Beyond the preview

Go deeper on BCL2 interacting protein 3 pseudogene 41 (BNIP3P41).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BCL2 interacting protein 3 pseudogene 41 (BNIP3P41).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call